Characterization and application of fusidane antibiotic biosynethsis enzyme 3-ketosteroid-∆ 1 -dehydrogenase in steroid transformation

Miao-Miao Chen,Feng-Qing Wang,Liang-Cai Lin,Kang Yao,Dong-Zhi Wei
DOI: https://doi.org/10.1007/s00253-011-3855-5
IF: 5
2012-01-01
Applied Microbiology and Biotechnology
Abstract:Microbial ∆ 1 - dehydrogenation is one of the most important transformations in the synthesis of steroid hormones. In this study, a 3-ketosteroid-∆ 1 -dehydrogenase (kstD F ) involved in fusidane antibiotic biosynthesis from Aspergillus fumigatus CICC 40167 was characterized for use in steroid transformation. KstD F encodes a polypeptide consisting of 637 amino acid residues. It shows 51% amino acid identity with a kstD from Thermomicrobium roseum DSM 5159. Expression of kstD F in Escherichia coli and Pichia pastoris showed that all kstD F activity is located in the cytoplasm. This indicates that it is a soluble intracytoplasmic enzyme, unlike most kstDs from bacteria, which are membrane-bound. The expression of kstD F was performed in P. pastoris , both intracellularly and extracelluarly. The intracellularly expressed protein displayed good activity in steroid transformation, while the extracellularly expressed protein showed nothing. Interestingly, the engineered P. pastoris KM71 (KM71 I ) and GS115 (GS115 I ) showed different transformation activities for 4-androstene-3,17-dione (AD) when kstD F was expressed intracellularly. Under the same conditions, KM71 I was found capable of transforming 1.0 g/l AD to 1,4-androstadiene-3,17-dione (ADD), while GS115 I could transform 1.5 g/l AD to both ADD and boldenone (BD). The production of BD is attributed to a 17β-hydroxysteroid dehydrogenase in P. pastoris GS115 I , which catalyzes the reversible reaction between C17-one and C17-alcohol of steroids. The conversion of AD by GS115 I and KM71 I may provide alternative means of preparing ADD or BD. In brief, we show here that kstD F is a promising enzyme in steroid ∆ 1 - dehydrogenation that is propitious to construct genetically engineered steroid-transforming recombinants by heterologous overexpression.
What problem does this paper attempt to address?